Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility and safety of intensified preoperative glucose control in type 2 diabetes patients undergoing major cardiovascular surgery
2014-000980-42Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Vienna. Primary endpoint: Preoperative target blood glucose achievement and safety. Started Sep 2014; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-000980-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000980-42.